基于18F-FDG PET/CT的影像组学模型对乳腺癌新辅助化疗疗效的预测价值:一项多扫描仪/多中心研究及外部验证
该研究回顾性纳入多中心193例乳腺癌患者,基于肿瘤与肝脏比值(TLR)影像组学特征及多种数据预处理方法构建并验证18F-FDG PET/CT模型预测新辅助化疗(NAC)疗效。共创建630个模型,筛选出7个优秀模型并选出最优模型,其四个测试组AUC在0.7至0.77之间,置换检验P值均小于0.05。结论认为通过数据预处理消除混杂因素可增强模型预测效果,所建模型能有效预测乳腺癌NAC疗效。
要点
- 多中心回顾性纳入193例乳腺癌患者,按NAC终点分为病理完全缓解(pCR)与非pCR组。
- 基于TLR影像组学特征及不同批次效应消除与离散化方法共构建630个模型。
- 最优模型在四个测试组AUC为0.7至0.77,置换检验P值均小于0.05。
核心结论
- 通过数据预处理消除混杂因素可增强模型预测效果,所建模型能有效预测乳腺癌NAC疗效。
研究设计与样本
- 回顾性纳入多中心193例乳腺癌患者,所有患者于NAC治疗前接受18F-FDG PET/CT成像。
- CT与PET图像分别采用手动分割和半自动绝对阈值分割勾画感兴趣体积(VOI),并使用pyradiomics包提取特征。
- 基于影像组学特征来源、批次效应消除方法和离散化方法共创建630个模型,通过比较数据预处理方法差异筛选最佳模型并进行置换检验。
主要发现
- 多种数据预处理方法对模型效果有不同程度的提升。
- TLR影像组学特征以及Combat和Limma批次效应消除方法总体上可增强模型预测。
- 数据离散化可作为进一步优化模型的潜在方法。
- 共选出7个优秀模型,基于四个测试集中各模型AUC及其标准差选出最优模型,其四个测试组AUC在0.7至0.77之间,置换检验P值均小于0.05。
关键数值与推荐
- 最优模型在四个测试组的AUC范围为0.7至0.77,置换检验P值均小于0.05。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop and validate the predictive value of an 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) model for breast cancer neoadjuvant chemotherapy (NAC) efficacy based on the tumor-to-liver ratio (TLR) radiomic features and multiple data pre-processing methods. METHODS: One hundred and ninety-three breast cancer patients from multiple centers were retrospectively included in this study. According to the endpoint of NAC, we divided the patients into pathological complete remission (pCR) and non-pCR groups. All patients underwent 18F-FDG PET/CT imaging before NAC treatment, and CT and PET images volume of interest (VOI) segmentation by manual segmentation and semi-automated absolute threshold segmentation, respectively. Then, feature extraction of VOI was performed with the pyradiomics package. A total of 630 models were created based on the source of radiomic features, the elimination of the batch effect approach, and the discretization method. The differences in data pre-processing approaches were compared and analyzed to identify the best-performing model, which was further tested by the permutation test. RESULTS: A variety of data pre-processing methods contributed in varying degrees to the improvement of model effects. Among them, TLR radiomic features and Combat and Limma methods that eliminate batch effects could enhance the model prediction overall, and data discretization could be used as a potential method that can further optimize the model. A total of seven excellent models were selected and then based on the AUC of each model in the four test sets and their standard deviations, we selected the optimal model. The optimal model predicted AUC between 0.7 and 0.77 for the four test groups, with p-values less than 0.05 for the permutation test. CONCLUSION: It is necessary to enhance the predictive effect of the model by eliminating confounding factors through data pre-processing. The model developed in this way is effective in predicting the efficacy of NAC for breast cancer.
引用
- Chen K, Wang J, Li S, et al. Predictive value of 18F-FDG PET/CT-based radiomics model for neoadjuvant chemotherapy efficacy in breast cancer: a multi-scanner/center study with external validation. Eur J Nucl Med Mol Imaging. 2023. PMID: 36808002. doi:10.1007/s00259-023-06150-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。